EVLVW vs JNJ · rev $29.1M vs P/E 17, rev $49.37B
Evolv Technologies Holdings Inc (EVLVW) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Evolv Technologies Holdings Inc (EVLVW) common stock listed on NASDAQ.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported EVLVW revenue for 2024-12-31 was $29.1M. Net income was -$15.7M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. EVLVW currently screens at market cap $0.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
EVLVW currently screens at market cap $0. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the EVLVW and JNJ stock pages for the full models.
Not investment advice.